Predictmedix Inc. is an artificial intelligence ("AI") company developing disruptive and cutting-edge tools for impairment testing and healthcare testing. The Issuer's proprietary technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. The Issuer is also developing cutting edge screening technologies for the healthcare industry. Predictmedix Inc. is expanding its proprietary AI technology to screen for infectious diseases, and also to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer’s disease.
Predictmedix Inc. (PMED)
Le 8 avril/April 2020
Cultivar Holdings Inc. has announced a name and symbol change to Predictmedix Inc. (PMED).
Shares will begin trading under the new name and symbol on April 9, 2020.
Disclosure documents are available at www.thecse.com
Please note that all open orders will be cancelled at the end of business on April 8, 2020. Dealers are reminded to re-enter their orders.